Holen Sie sich die Stockscreener-App
9.46
4.06%
-0.40
Handel nachbörslich:
9.46
Schlusskurs vom Vortag:
$9.86
Offen:
$9.7
24-Stunden-Volumen:
468.18K
Relative Volume:
0.83
Marktkapitalisierung:
$509.26M
Einnahmen:
$217.25M
Nettoeinkommen (Verlust:
$-50.92M
KGV:
-9.46
EPS:
-1
Netto-Cashflow:
$-100.85M
1W Leistung:
+9.49%
1M Leistung:
+13.29%
6M Leistung:
+10.64%
1J Leistung:
-36.72%
1-Tages-Spanne:
$9.36
$10.06
1-Wochen-Bereich:
$8.48
$10.06
52-Wochen-Spanne:
$4.32
$15.63
Prothena Corporation Plc Stock (PRTA) Company Profile
Firmenname
Prothena Corporation Plc
Sektor
Branche
Telefon
011-353-1-236-2500
Adresse
77 SIR JOHN ROGERSON'S QUAY, BLOCK C, DUBLIN 2
Compare PRTA vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRTA
Prothena Corporation Plc
|
9.46 | 530.79M | 217.25M | -50.92M | -100.85M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.14 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Prothena Corporation Plc Stock (PRTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-28 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-05-27 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-05-27 | Herabstufung | Jefferies | Buy → Hold |
| 2025-05-27 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-12-20 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-01-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-04-24 | Eingeleitet | SVB Securities | Outperform |
| 2023-01-27 | Eingeleitet | Piper Sandler | Overweight |
| 2022-11-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-28 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-11-19 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-06-18 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-06-08 | Bestätigt | Oppenheimer | Outperform |
| 2021-05-26 | Eingeleitet | Citigroup | Buy |
| 2021-02-26 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-02-12 | Hochstufung | Jefferies | Hold → Buy |
| 2021-02-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-12-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-07-09 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2019-11-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-05-21 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2018-04-23 | Herabstufung | Jefferies | Buy → Hold |
| 2018-04-05 | Bestätigt | Barclays | Overweight |
| 2017-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2017-09-29 | Bestätigt | BTIG Research | Buy |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-11 | Eingeleitet | Jefferies | Buy |
| 2017-04-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-04-12 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-03-02 | Eingeleitet | Instinet | Buy |
| 2016-12-21 | Eingeleitet | SunTrust | Buy |
| 2016-11-03 | Eingeleitet | Deutsche Bank | Buy |
| 2016-08-04 | Bestätigt | Barclays | Overweight |
| 2016-05-13 | Eingeleitet | Barclays | Overweight |
| 2016-02-19 | Bestätigt | Wedbush | Outperform |
| 2016-01-21 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Prothena Corporation Plc Aktie (PRTA) Neueste Nachrichten
Prothena: A Hold With 2 Late-Stage Programs Underway But With Caution (NASDAQ:PRTA) - Seeking Alpha
Wall Street Analysts Believe Prothena (PRTA) Could Rally 118.09%: Here's is How to Trade - sharewise.com
Prothena (NASDAQ:PRTA) Shares Up 8.7%Still a Buy? - MarketBeat
Prothena Corporation plc (NASDAQ:PRTA) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Prothena Corporation plc (NASDAQ:PRTA) Given Average Recommendation of “Hold” by Analysts - Defense World
PRTA SEC FilingsProthena 10-K, 10-Q, 8-K Forms - Stock Titan
Prothena Corporation plc (PRTA) Stock Analysis: Navigating a 137% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Prothena Announces $100 Million Share Repurchase Program - TipRanks
Prothena authorizes $100 million share buyback program - Investing.com
Prothena Corporation plc announces an Equity Buyback for $100 million worth of its shares. - marketscreener.com
Prothena (NASDAQ: PRTA) okays $100M share buyback through 2026 - Stock Titan
Prothena Approves $100 Million Share Buyback Authorization - marketscreener.com
Prothena stock jumps on $100M share buyback authorization By Investing.com - Investing.com UK
Prothena Corporation plc (NASDAQ: PRTA) clears shelf to sell up to $200M in shares - Stock Titan
Prothena Announces up to $100 Million Share Repurchase Plan - The Joplin Globe
PROTHENA CORP PUBLIC LTD CO SEC 10-K Report - TradingView
Prothena (NASDAQ: PRTA) reshapes pipeline and cuts staff in 10-K - Stock Titan
Prothena Corporation plc authorizes a Buyback Plan. - marketscreener.com
Behavioral Patterns of PRTA and Institutional Flows - Stock Traders Daily
FY2026 EPS Estimates for Prothena Boosted by HC Wainwright - MarketBeat
Royal Bank Of Canada Increases Prothena (NASDAQ:PRTA) Price Target to $12.00 - Defense World
RBC Capital Raises Price Target for Prothena Corp (PRTA) to $12. - GuruFocus
Prothena Q4 Earnings Meet Estimates, Pipeline Progress in Focus - Finviz
Prothena (NASDAQ:PRTA) Price Target Raised to $12.00 - MarketBeat
Prothena Corporation plc (NASDAQ:PRTA) Q4 2025 Earnings Call Transcript - Insider Monkey
Prothena Corporation plc Q4 2025 Earnings Call Summary - Yahoo Finance
Prothena Corp PLC (PRTA) Q4 2025 Earnings Call Highlights: Strat - GuruFocus
Prothena Q4 Earnings Call Highlights - MarketBeat
Can Prothena Corporation plc be recession proofTrade Exit Summary & Growth Focused Stock Reports - mfd.ru
Prothena (PRTA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Prothena (PRTA) Projects Financial Outlook and Clinical Milestones - GuruFocus
Prothena Corporation plc announced that the company has the potential to receive up to $105 million in cumulative clinical milestone payments by the end of 2026. - Bitget
Prothena (NASDAQ:PRTA) Releases Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Prothena Reports Fourth Quarter and Full Year 2025 Financial Results, and Provides Financial Guidance and Business Highlights - The Joplin Globe
Exploring Prothena Corp's Earnings Expectations - Benzinga
Prothena Stock Tumbles 36.8% Year Over Year: What Lies Ahead? - Finviz
(PRTA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Will Prothena Corporation plc stock remain a Wall Street favoriteQuarterly Portfolio Review & AI Optimized Trading Strategy Guides - mfd.ru
Prothena Corporation plc (PRTA) Stock Analysis: Exploring a 129.76% Potential Upside in Biotechnology - DirectorsTalk Interviews
Prothena to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 - pharmiweb.com
Prothena (PRTA) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Is Prothena Corporation plc stock affected by interest rate hikes2025 Retail Activity & Short-Term Trading Opportunity Alerts - mfd.ru
Will Prothena Corporation plc benefit from rising consumer demandJuly 2025 Retail & Stepwise Swing Trade Plans - mfd.ru
Aug Levels: Will Prothena Corporation plc benefit from rising consumer demandMarket Performance Recap & High Accuracy Trade Alerts - baoquankhu1.vn
Volatility Watch: How do insiders feel about Prothena Corporation plcWeekly Stock Report & Smart Money Movement Tracker - baoquankhu1.vn
Prothena Corporation plc (NASDAQ:PRTA) Given Average Rating of "Hold" by Analysts - MarketBeat
How (PRTA) Movements Inform Risk Allocation Models - Stock Traders Daily
Prothena Corporation plc $PRTA Shares Sold by Federated Hermes Inc. - MarketBeat
Prothena Corporation plc (PRTA) Stock Analysis: Exploring a Potential 124% Upside in Biotech Innovations - DirectorsTalk Interviews
Prothena (NASDAQ:PRTA) Share Price Crosses Above 50 Day Moving AverageHere's Why - MarketBeat
Can Calidi Biotherapeutics Inc reach resistance levels soonWeekly Stock Summary & Community Trade Idea Sharing - baoquankhu1.vn
Finanzdaten der Prothena Corporation Plc-Aktie (PRTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Prothena Corporation Plc-Aktie (PRTA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 10% Owner |
May 06 '25 |
Sale |
7.64 |
1,984,053 |
15,164,712 |
5,304,596 |
| EcoR1 Capital, LLC | 10% Owner |
May 05 '25 |
Sale |
8.11 |
977,693 |
7,930,166 |
7,288,649 |
3.69%
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):